ストックスクリーナーアプリを入手
11.90
2.54%
-0.31
前日終値:
$12.21
開ける：
$12.39
24時間の取引高:
118.43K
Relative Volume:
0.72
時価総額：
$323.50M
収益：
$56.44M
当期純損益:
$-32.60M
株価収益率:
-9.6607
EPS:
-1.2318
ネットキャッシュフロー:
$-35.15M
1週間 パフォーマンス:
+4.94%
1か月 パフォーマンス:
+3.93%
6か月 パフォーマンス:
-6.23%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$11.57
$12.39
1週間の範囲:
$11.31
$13.06
52週間の値動き範囲:
$8.50
$17.19
Carlsmed Inc Stock (CARL) Company Profile
Compare CARL vs VEEV, BTSG, TEM, HQY, HNGE
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CARL
Carlsmed Inc
|
11.90 | 323.50M | 56.44M | -32.60M | -35.15M | -1.2318 |
VEEV
Veeva Systems Inc
|
190.12 | 30.88B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
71.43 | 14.02B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
58.23 | 10.46B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
94.40 | 7.89B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
88.80 | 6.87B | 646.34M | -512.40M | 202.76M | -6.6871 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-18 | 開始されました | BTIG Research | Buy |
| 2025-08-18 | 開始されました | BofA Securities | Buy |
| 2025-08-18 | 開始されました | Goldman | Buy |
| 2025-08-18 | 開始されました | Piper Sandler | Overweight |
| 2025-08-18 | 開始されました | Truist | Buy |
Carlsmed Inc (CARL) 最新ニュース
Possible Turnaround For Carlsmed Insiders, Still Down US$1.7m - 富途牛牛
CARL Initiates Coverage On Needham -- Rating Set to Buy - GuruFocus
Needham initiates Carlsmed stock with buy rating on implant differentiation By Investing.com - Investing.com Nigeria
Needham initiates Carlsmed stock with buy rating on implant differentiation - Investing.com
Needham Initiates Carlsmed(CARL.US) With Buy Rating, Announces Target Price $17 - Moomoo
CARL Forecast — Price Target — Prediction for 2027 - TradingView
Carlsmed, Inc. Actuals & Estimates (NASDAQ:CARL) - TradingView
Carlsmed, Inc. Actuals & Estimates (DUS:I82) - TradingView
Price to sales forward of Carlsmed, Inc. – NASDAQ:CARL - TradingView
Enterprise value to revenue forward of Carlsmed, Inc. – NASDAQ:CARL - TradingView
CARL Q1 2026 Earnings: Narrower Loss Beats Estimates as Clinical Progress ContinuesPre-Announcement Alert - dars.gov.et
I82 Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBITDA forward of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Enterprise value to revenue forward of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Carlsmed, Inc. Actuals & Estimates (LSX:A41CM7) - TradingView
A41CM7 Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Price to book forward of Carlsmed, Inc. – NASDAQ:CARL - TradingView
Price to sales forward of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Carlsmed Inc. (CARL) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
BTIG Maintains Carlsmed(CARL.US) With Buy Rating, Maintains Target Price $23 - Moomoo
Form 4 Carlsmed Inc For: 22 June By Investing.com - Investing.com Nigeria
CARL Q1 2026 Earnings: EPS Beats Estimates as Pre-Revenue Company Focuses on Personalized Spine ExpansionSpecial Dividend Alert - dars.gov.et
Carlsmed Ord Shs (CARL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CARL: AI-driven personalized surgery platform accelerates growth and efficiency, outpacing traditional models - TradingView
CARLSMED INC (CARL) Stock Chart - ChartMill
Wall Street analysts think Carlsmed, Inc. (CARL) could surge 90.77%: Read this before placing a bet - MSN
CARL Q1 2026 Earnings: Narrower-than-Expected Loss as Development Progress ContinuesPeak Earnings Alert - newsline.com
Carlsmed Shareholders Back Directors and Auditor at Meeting - TipRanks
Carlsmed Stock Faces A Crucial Week After Friday’s Drop - Bez Kabli
Carlsmed, Inc. Cash Flow – LSX:A41CM7 - TradingView
CARL Q1 2026 Earnings: Personal Surgery Specialist Beats EPS Estimates; Stock RisesEarnings Surprise Score - The Legal Advocate
CARLCarlsmed Inc Stock Price and Quote - Finviz
Wall Street analysts see a 51.94% upside in Carlsmed, Inc. (CARL): Can the stock really move this high? - MSN
Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High? - sharewise.com
Basic earnings per share (basic EPS) of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Carlsmed (CARL) Stock: Jumps +3.57%, Approaching $11.89 2026-05-19Free Signal Network - Newser
Carlsmed (CARL) Down -1.66% — How Low Could It Go? 2026-05-14Earnings Breakout - newser.com
Price to cash flow ratio of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Return on equity % of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Total equity of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Carlsmed, Inc. Income Statement – LSX:A41CM7 - TradingView
Carlsmed raises FY 2026 revenue outlook to $72M-$77M as CMS proposes new MS-DRGs for Aprevo lumbar - MSN
Top Carlsmed (CARL) Competitors 2026 - MarketBeat
Number of shareholders of Carlsmed, Inc. – NASDAQ:CARL - TradingView
Carlsmed, Inc. Dividends – LS:A41CM7 - TradingView
Number of employees of Carlsmed, Inc. – LS:A41CM7 - TradingView
Operating expenses (excl. COGS) of Carlsmed, Inc. – LS:A41CM7 - TradingView
Enterprise value to EBITDA ratio of Carlsmed, Inc. – LS:A41CM7 - TradingView
Total debt per share of Carlsmed, Inc. – LS:A41CM7 - TradingView
Carlsmed Inc (CARL) 財務データ
収益
当期純利益
現金流量
EPS
Carlsmed Inc (CARL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Cordonnier Michael | CEO, President |
Mar 02 '26 |
Option Exercise |
0.34 |
197,855 |
66,281 |
1,554,501 |
| Cordonnier Michael | CEO, President |
Mar 02 '26 |
Sale |
13.29 |
197,855 |
2,629,889 |
1,356,646 |
3.61%
大文字化:
|
ボリューム (24 時間):